XPAND Trial: Enhancing XP Photoprotection Activities – New Directions
Condition(s):Xeroderma PigmentosumLast Updated:July 22, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Xeroderma PigmentosumLast Updated:July 22, 2020Completed
Condition(s):Vitiligo; PHOTOPROTECTION; SUN-EXPOSITION; FITZPATRICK SCALELast Updated:June 26, 2018Completed
Condition(s):Infant, PrematureLast Updated:May 28, 2019Completed
Condition(s):Solar Skin DamageLast Updated:May 29, 2013Completed
Condition(s):Parenteral Nutrition; Infant, Premature, Diseases; Infant, Newborn, Disease; Lung Diseases; Respiratory Tract Disease; Bronchopulmonary Dysplasia; Pathologic ProcessesLast Updated:October 31, 2022Completed
Condition(s):Covid19; Corona Virus Infection; Autoimmune Diseases; Coagulation Disorder, BloodLast Updated:June 15, 2022Completed
Condition(s):MelasmaLast Updated:December 2, 2014Completed
Condition(s):Preterm InfantsLast Updated:February 11, 2008Completed
Condition(s):PhototoxicityLast Updated:August 22, 2019Completed
Condition(s):Pigmentation; RednessLast Updated:April 29, 2021Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.